2024.12.04

JAK1/2 Inhibitor Ruxolitinib for the Treatment of Systemic Chronic Active Epstein-Barr Virus Disease: A Phase II Study, Masataka Ishimura, Department of Perinatal and Pediatric Medicine

2024.11.14

Common protein-altering variant in GFAP is associated with white matter lesions in the older Japanese population, Toshiharu Ninomiya, Department of Epidemiology and Public Health

2024.10.04

Pre- and postoperative Coronal Plane Alignment of the Knee classification and its impact on clinical outcomes in total knee arthroplasty, Toshiki Konishi and Satoshi Hamai, Department of Orthopaedic Surgery.

2024.09.26

A sustained calcium response mediated by IP3 receptor anchoring to the desmosome is essential for apoptotic cell elimination, Junichi Ikenouchi, Department of Biochemistry

2024.09.25

Glucose metabolism and smaller hippocampal volume in elderly people with normal cognitive function, Toshiharu Ninomiya, Department of Epidemiology and Public Health

2024.09.18

ctDNA-based molecular residual disease and survival in resectable colorectal cancer, Eiji Oki, Department of Surgery and Science

2024.07.30

The Derlin-1-Stat5b axis maintains homeostasis of adult hippocampal neurogenesis

2024.07.29

Strategic Targeting of Cas9 Nickase Induces Large Segmental Duplications

2024.07.23

Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals

2024.07.01

Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model